Cardio Diagnostics Holdings Stock Alpha and Beta Analysis
| CDIO Stock | USD 0.27 0.02 8.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cardio Diagnostics Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cardio Diagnostics over a specified time horizon. Remember, high Cardio Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cardio Diagnostics' market risk premium analysis include:
Beta 4.79 | Alpha (0.94) | Risk 9.5 | Sharpe Ratio (0.03) | Expected Return (0.24) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cardio |
Cardio Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cardio Diagnostics market risk premium is the additional return an investor will receive from holding Cardio Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cardio Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cardio Diagnostics' performance over market.| α | -0.94 | β | 4.79 |
Cardio Diagnostics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cardio Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Cardio Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cardio Diagnostics Market Price Analysis
Market price analysis indicators help investors to evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By understating and applying Cardio Diagnostics stock market price indicators, traders can identify Cardio Diagnostics position entry and exit signals to maximize returns.
Cardio Diagnostics Return and Market Media
The median price of Cardio Diagnostics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.27 with a coefficient of variation of 23.71. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 0.28, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Meeshanthini Dogan of 68965 shares of Cardio Diagnostics at 0.29 subject to Rule 16b-3 | 09/06/2024 |
2 | Potential Catalyst Right Around The Corner CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics Heart Disease Tests | 09/17/2024 |
3 | Acquisition by Philibert Robert of 7460 shares of Cardio Diagnostics at 0.2848 subject to Rule 16b-3 | 09/19/2024 |
4 | Acquisition by Lau Stanley K. of tradable shares of Cardio Diagnostics subject to Rule 16b-3 | 09/20/2024 |
5 | Acquisition by Burton Paul Frederick of 18686 shares of Cardio Diagnostics at 0.22 subject to Rule 16b-3 | 09/30/2024 |
6 | Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services for AI-Powered Cardiovascular Tests | 10/01/2024 |
7 | Cardio Diagnostics shareholders approve key proposals | 11/18/2024 |
About Cardio Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cardio or other stocks. Alpha measures the amount that position in Cardio Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Days Sales Outstanding | 95.48 | 84.87 | PTB Ratio | 10.68 | 10.14 |
Cardio Diagnostics Upcoming Company Events
As portrayed in its financial statements, the presentation of Cardio Diagnostics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cardio Diagnostics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cardio Diagnostics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cardio Diagnostics. Please utilize our Beneish M Score to check the likelihood of Cardio Diagnostics' management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cardio Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cardio Diagnostics Backtesting, Cardio Diagnostics Valuation, Cardio Diagnostics Correlation, Cardio Diagnostics Hype Analysis, Cardio Diagnostics Volatility, Cardio Diagnostics History and analyze Cardio Diagnostics Performance. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.